Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 2;24(1):275.
doi: 10.1186/s13054-020-03025-y.

Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study

Megan Fraissé  1 , Elsa Logre  1 , Olivier Pajot  1 , Hervé Mentec  1 , Gaëtan Plantefève  1 , Damien Contou  2
Affiliations

Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study

Megan Fraissé et al. Crit Care. .
No abstract available

Keywords: ARDS; COVID-19; D-dimers; Intensive care; Pulmonary embolism; SARS-CoV-2; Thrombosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Description of thrombotic and hemorrhagic events among 92 critically ill COVID-19 patients
See this image and copyright information in PMC

Comment in

References

    1. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost JTH. 2020. - PMC - PubMed
    1. Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D A. MPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;. - PMC - PubMed
    1. Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020. - PMC - PubMed
    1. Susen S, Tacquard CA, Godon A, Mansour A, Nguyen P, Godier A, et al. Traitement anticoagulant pour la prevention du risque thrombotique chez un patient hospitalise avec covid-19 et surveillance de l’hemostase propositions du GIHP et du GFHT. Available at https://site.geht.org/app/uploads/2020/04/COVID-19-GIHP-GFHT-3-avril-fin....
    1. Llitjos J, Leclerc M, Chochois C, Monsallier J, Ramakers M, Auvray M, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020; Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.14869. [cited 2020 May 9]. - DOI - PMC - PubMed